Quadrature Capital Ltd Takes $261,000 Position in agilon health, inc. (NYSE:AGL)

Quadrature Capital Ltd acquired a new position in shares of agilon health, inc. (NYSE:AGL) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 66,549 shares of the company’s stock, valued at approximately $261,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Citigroup Inc. boosted its position in shares of agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares during the period. AQR Capital Management LLC grew its position in agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after acquiring an additional 1,316,990 shares in the last quarter. Bank of New York Mellon Corp increased its stake in agilon health by 18.7% during the second quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock worth $7,252,000 after purchasing an additional 174,883 shares during the period. Susquehanna Fundamental Investments LLC lifted its position in shares of agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after purchasing an additional 316,856 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of agilon health by 6.3% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 640,048 shares of the company’s stock valued at $2,515,000 after purchasing an additional 37,725 shares during the period.

Analyst Ratings Changes

A number of equities research analysts have issued reports on AGL shares. TD Cowen reduced their target price on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Citigroup cut their price target on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a report on Wednesday, November 13th. Barclays decreased their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday, November 11th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $3.00 target price on shares of agilon health in a report on Tuesday, November 19th. Three investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, agilon health has an average rating of “Hold” and a consensus target price of $5.20.

agilon health Stock Performance

Shares of AGL opened at $2.10 on Wednesday. The company’s 50 day simple moving average is $2.51 and its 200-day simple moving average is $4.46. The firm has a market cap of $865.24 million, a PE ratio of -2.23 and a beta of 0.51. agilon health, inc. has a 12-month low of $1.50 and a 12-month high of $13.76. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. During the same period in the previous year, the business posted ($0.06) earnings per share. As a group, equities analysts predict that agilon health, inc. will post -0.5 EPS for the current year.

Insider Buying and Selling at agilon health

In other news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were purchased at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the transaction, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. This represents a 42.03 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. 3.20% of the stock is owned by company insiders.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.